Acquiring Company
Novonesis
Acquired Company
MicroBioGen
Copenhagen
AustraliaManufacturingAgriculture and FarmingBiotechnologyDescription
Novonesis has completed its acquisition of MicroBioGen, enhancing its yeast capabilities. The deal was finalized after obtaining all necessary regulatory approvals. This acquisition builds upon Novonesis' previous investment and ownership stake in MicroBioGen. It aims to leverage combined expertise for developing innovative biosolutions across multiple industries.
Fundz sees it the moment Novonesis makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired MicroBioGen?
MicroBioGen was acquired by Novonesis, based in Copenhagen. The deal was reported on October 1, 2026. Novonesis is a global leader in biosolutions, specializing in fermentation technology. The company focuses on innovative production methods to meet growing customer demands. Novonesis is privately held and operates in Manufacturing.
When did Novonesis acquire MicroBioGen?
Novonesis's acquisition of MicroBioGen was reported on October 1, 2026. Novonesis has completed its acquisition of MicroBioGen, enhancing its yeast capabilities. The deal was finalized after obtaining all necessary regulatory approvals. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does MicroBioGen do?
MicroBioGen is an Australian biotechnology company that specializes in yeast strain improvements for industrial applications. They have developed elite yeast genetics over 20 years and provide ‘Yeast Innovation as a Service’ to global industry leaders. It is privately held, operating in Biotechnology, and is based in Australia.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.